Targeted modification of furan‐2‐carboxaldehydes into Michael acceptor analogs yielded <scp>long‐acting</scp> hemoglobin modulators with dual antisickling activitiesAbdelsattar M. Omar, Martin K. Safo, Mohammed A. AlAwadh et al.|Chemical Biology & Drug Design|2023Cited by 5
Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantationJohn S. Riley, William H. Peranteau, Cara Berkowitz et al.|Blood Advances|2024Cited by 4
ILX-002 A Direct HbS Polymerization Inhibitor for the Treatment of Sickle Cell DiseaseOsheiza Abdulmalik, Martin K. Safo, Abdelsattar M. Omar et al.|Journal of sickle cell disease.|2024Cited by 0